Mouse clinical trials of pancreatic cancer: Integration of PDX models with genomics to improve patient outcomes to chemotherapeutics

被引:2
|
作者
Davies, A. [1 ]
Hidalgo, M. [2 ]
Stebbing, J. [3 ]
Ciznadija, D. [4 ]
Katz, A. [4 ]
Sidransky, D. [5 ]
机构
[1] Champ Oncol, Med Affairs, Hackensack, NJ USA
[2] Hosp Madrid Norte San Chinarro, Ctr Integral Oncol Clara Campal, CIOCC, Madrid, Spain
[3] Imperial Coll London, Hammersmith Hosp, Surg & Canc, London, England
[4] Champ Oncol, Translat Oncol, Hackensack, NJ USA
[5] Johns Hopkins Univ Hosp, Med, Baltimore, MD 21287 USA
关键词
D O I
10.1093/annonc/mdw392.4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1522P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Patient-reported outcomes (PROs) in pancreatic cancer clinical trials (CTs)
    Grewal, Udhayvir Singh
    Ahmed, Danya
    Dhaliwal, Lovekirat Singh
    Laheru, Daniel A.
    Lou, Emil
    Beg, Muhammad Shaalan
    Nipp, Ryan David
    Gupta, Arjun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [2] INTEGRATION OF CLINICAL AND RESEARCH TEAMS IMPROVE PATIENT ENROLLMENT IN CLINICAL TRIALS
    Sabbatini, G. M.
    Britton, L. J.
    Hathorne, H. Y.
    Reeves, G. A.
    Lucious, T. D.
    PEDIATRIC PULMONOLOGY, 2010, : 400 - 400
  • [3] Evaluation of the correlations between patient-derived xenograft (PDX) model-based mouse trials and cancer patient-based clinical trials.
    Gu, Zhenyu
    Jiang, Jingjing
    Yan, Ying
    Tan, Tingting
    Yu, Tengfei
    Liu, Zhenhua
    Du, Wei
    Yang, Xuqin
    Qiu, Ling
    Ye, X. Katherine
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Analysis of murine stromal components in patient derived xenograft (PDX) models of pancreatic cancer
    Behrens, D.
    Pfohl, U.
    Hallas, C.
    Buettner, B.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S59 - S60
  • [5] INCORPORATING A DISTRESS THERMOMETER TO IMPROVE PATIENT OUTCOMES IN PANCREATIC CANCER
    Hampton, Janet
    Henrickson, Chris
    Griffith, Kent
    Zalupski, Mark
    ONCOLOGY NURSING FORUM, 2011, 38 (02) : E129 - E129
  • [6] Patient and caregiver awareness of pancreatic cancer treatments and clinical trials
    Engebretson, Anitra
    Matrisian, Lynn
    Thompson, Cara
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (02) : 228 - 233
  • [7] Integration of patient-reported outcomes in multiregional confirmatory clinical trials
    Gnanasakthy, Ari
    DeMuro, Carla
    Boulton, Caroline
    CONTEMPORARY CLINICAL TRIALS, 2013, 35 (01) : 62 - 69
  • [8] Identifying Human DNA in a cfDNA Component of Pancreatic Cancer Patient Derived Xenograft (PDX) Models
    Gallagher, T. L.
    Soares, B. L.
    Fischer, D. L.
    Lara dos Santos, L.
    Burchard, P. R.
    Suriawinata, A. A.
    Padmanabhan, V.
    Smith, K. D.
    Tsongalis, G. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 776 - 776
  • [9] Analysis of murine stromal components in patient-derived xenograft (PDX) models of pancreatic cancer
    Behrens, Diana
    Pfohl, Ulrike
    Buttner, Britta
    Hoffmann, Jens
    Walther, Wolfgang
    Fichtner, Iduna
    CANCER RESEARCH, 2016, 76
  • [10] Looking Beyond Historical Patient Outcomes to Improve Clinical Models
    Chia, Chih-Chun
    Rubinfeld, Ilan
    Scirica, Benjamin M.
    McMillan, Sean
    Gurm, Hitinder S.
    Syed, Zeeshan
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (131)